aluminium chloride hexahydrate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
aluminium chloride hexahydrate: clinical details
Prescribing considerations
- Confirm that sweating is focal; generalised or night-time sweating may warrant assessment for an underlying condition or medicine-related cause.
- Application to completely dry skin improves duct penetration and reduces irritation.
- Restrict use to the licensed treatment sites and minimise unnecessary widespread sweat-duct obstruction.
Contraindications and cautions
- Hypersensitivity to aluminium chloride hexahydrate or another ingredient.
- Avoid application to broken or irritated skin, eyes and mucous membranes.
Monitoring
- Assess symptom response and effect on daily activities.
- Check for local irritation and review application technique if it occurs.
- Persistent, severe or generalised sweating warrants reassessment for an underlying cause.
Clinical pharmacology
The alcoholic vehicle evaporates after carrying aluminium chloride into terminal eccrine pores. Protein denaturation and interaction with intraductal keratin create functional duct closure; pressure-mediated feedback subsequently suppresses acinar secretion.
Formulation and product differences
- The selected product is a clear, colourless, fragrance-free cutaneous solution in an alcohol-based roll-on formulation.
- It is highly flammable and should be stored upright, with the cap closed, away from ignition sources.
aluminium chloride hexahydrate interactions
No clinically relevant medicine interactions are known for the selected product.
Other medicines
Aluminium chloride hexahydrate is not known to affect, or be affected by, other medicines.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.